_id
6915e8bebc934aba376b1b96
Ticker
PTGX
Name
Protagonist Therapeutics Inc
Exchange
NASDAQ
Address
7707 Gateway Boulevard, Newark, CA, United States, 94560
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.protagonist-inc.com
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Last Close
92.25
Volume
915141
Current Price
95.35
Change
3.3604336043360368
Last Updated
2025-12-03T12:29:13.604Z
Image
-
Ipo Date
2016-08-11T00:00:00.000Z
Market Cap
5291951104
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8390090909090909
Sentiment Sources
11
Rating
4.4
Target Price
90.6923
Strong Buy
5
Buy
4
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
4712000
Cost Of Revenue
-
Gross Profit
4712000
Operating Expenses
51133000
Operating Income
-46421000
Interest Expense
-
Pretax Income
-39339000
Net Income
-39339000
Eps
-0.6168662610613016
Dividends Per Share
-
Shares Outstanding
62515666
Income Tax Expense
-
EBITDA
-38978000
Operating Margin
-985.1655348047539
Total Other Income Expense Net
7082000
Cash
113713000
Short Term Investments
462404000
Receivables
583000
Inventories
-
Total Current Assets
586424000
Property Plant Equipment
12274000
Total Assets
701688000
Payables
5646000
Short Term Debt
2228000
Long Term Debt
-
Total Liabilities
56251000
Equity
645437000
Depreciation
361000
Change In Working Capital
28061000
Cash From Operations
-1937000
Capital Expenditures
88000
Cash From Investing
-58555000
Cash From Financing
5659000
Net Change In Cash
-54830000
PE
130.2308
PB
9.421046292976696
ROE
-6.094940327251149
ROA
-5.606337859561514
FCF
-2025000
Fcf Percent
-0.42975382003395585
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
4712000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
4712000
Quarters > 0 > income Statement > operating Expenses
51133000
Quarters > 0 > income Statement > operating Income
-46421000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-39339000
Quarters > 0 > income Statement > net Income
-39339000
Quarters > 0 > income Statement > eps
-0.6168662610613016
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
63772332
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-38978000
Quarters > 0 > income Statement > operating Margin
-985.1655348047539
Quarters > 0 > income Statement > total Other Income Expense Net
7082000
Quarters > 0 > balance Sheet > cash
113713000
Quarters > 0 > balance Sheet > short Term Investments
462404000
Quarters > 0 > balance Sheet > receivables
583000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
586424000
Quarters > 0 > balance Sheet > property Plant Equipment
12274000
Quarters > 0 > balance Sheet > total Assets
701688000
Quarters > 0 > balance Sheet > payables
5646000
Quarters > 0 > balance Sheet > short Term Debt
2228000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
56251000
Quarters > 0 > balance Sheet > equity
645437000
Quarters > 0 > cash Flow > net Income
-39339000
Quarters > 0 > cash Flow > depreciation
361000
Quarters > 0 > cash Flow > change In Working Capital
28061000
Quarters > 0 > cash Flow > cash From Operations
-1937000
Quarters > 0 > cash Flow > capital Expenditures
88000
Quarters > 0 > cash Flow > cash From Investing
-58555000
Quarters > 0 > cash Flow > cash From Financing
5659000
Quarters > 0 > cash Flow > net Change In Cash
-54830000
Quarters > 0 > ratios > PE
-0.6168662610613016
Quarters > 0 > ratios > PB
9.421046292976696
Quarters > 0 > ratios > ROE
-6.094940327251149
Quarters > 0 > ratios > ROA
-5.606337859561514
Quarters > 0 > ratios > FCF
-2025000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.42975382003395585
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
5546000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
5546000
Quarters > 1 > income Statement > operating Expenses
47587000
Quarters > 1 > income Statement > operating Income
-42041000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-34599000
Quarters > 1 > income Statement > net Income
-34771000
Quarters > 1 > income Statement > eps
-0.547479964100707
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
63511000
Quarters > 1 > income Statement > income Tax Expense
172000
Quarters > 1 > income Statement > EBITDA
-41737000
Quarters > 1 > income Statement > operating Margin
-758.0418319509556
Quarters > 1 > income Statement > total Other Income Expense Net
7442000
Quarters > 1 > balance Sheet > cash
168543000
Quarters > 1 > balance Sheet > short Term Investments
401922000
Quarters > 1 > balance Sheet > receivables
27971000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
602526000
Quarters > 1 > balance Sheet > property Plant Equipment
12697000
Quarters > 1 > balance Sheet > total Assets
718006000
Quarters > 1 > balance Sheet > payables
3249000
Quarters > 1 > balance Sheet > short Term Debt
2173000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
49988000
Quarters > 1 > balance Sheet > equity
668018000
Quarters > 1 > cash Flow > net Income
-34771000
Quarters > 1 > cash Flow > depreciation
304000
Quarters > 1 > cash Flow > change In Working Capital
-3879000
Quarters > 1 > cash Flow > cash From Operations
-28780000
Quarters > 1 > cash Flow > capital Expenditures
813000
Quarters > 1 > cash Flow > cash From Investing
54810000
Quarters > 1 > cash Flow > cash From Financing
2925000
Quarters > 1 > cash Flow > net Change In Cash
28955000
Quarters > 1 > ratios > PE
-0.547479964100707
Quarters > 1 > ratios > PB
9.06528544141026
Quarters > 1 > ratios > ROE
-5.205099263792293
Quarters > 1 > ratios > ROA
-4.842717191778342
Quarters > 1 > ratios > FCF
-29593000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-5.335917778579156
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
28321000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
28321000
Quarters > 2 > income Statement > operating Expenses
47631000
Quarters > 2 > income Statement > operating Income
-19310000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-11655000
Quarters > 2 > income Statement > net Income
-11655000
Quarters > 2 > income Statement > eps
-0.18510577472841624
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
62964000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-19071000
Quarters > 2 > income Statement > operating Margin
-68.18262067017407
Quarters > 2 > income Statement > total Other Income Expense Net
7655000
Quarters > 2 > balance Sheet > cash
139653000
Quarters > 2 > balance Sheet > short Term Investments
434707000
Quarters > 2 > balance Sheet > receivables
27088000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
605860000
Quarters > 2 > balance Sheet > property Plant Equipment
12530000
Quarters > 2 > balance Sheet > total Assets
742132000
Quarters > 2 > balance Sheet > payables
2917000
Quarters > 2 > balance Sheet > short Term Debt
1568000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
53080000
Quarters > 2 > balance Sheet > equity
689052000
Quarters > 2 > cash Flow > net Income
-11655000
Quarters > 2 > cash Flow > depreciation
239000
Quarters > 2 > cash Flow > change In Working Capital
124692000
Quarters > 2 > cash Flow > cash From Operations
125363000
Quarters > 2 > cash Flow > capital Expenditures
545000
Quarters > 2 > cash Flow > cash From Investing
-94402000
Quarters > 2 > cash Flow > cash From Financing
11443000
Quarters > 2 > cash Flow > net Change In Cash
42404000
Quarters > 2 > ratios > PE
-0.18510577472841624
Quarters > 2 > ratios > PB
8.712865502168196
Quarters > 2 > ratios > ROE
-1.691454345970986
Quarters > 2 > ratios > ROA
-1.570475333229129
Quarters > 2 > ratios > FCF
124818000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
4.407259630662759
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
170638000
Quarters > 3 > income Statement > cost Of Revenue
604000
Quarters > 3 > income Statement > gross Profit
170638000
Quarters > 3 > income Statement > operating Expenses
43858000
Quarters > 3 > income Statement > operating Income
126780000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
133664000
Quarters > 3 > income Statement > net Income
131674000
Quarters > 3 > income Statement > eps
1.982838599235979
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
66406817
Quarters > 3 > income Statement > income Tax Expense
1990000
Quarters > 3 > income Statement > EBITDA
127316000
Quarters > 3 > income Statement > operating Margin
74.29763593103529
Quarters > 3 > income Statement > total Other Income Expense Net
6884000
Quarters > 3 > balance Sheet > cash
97249000
Quarters > 3 > balance Sheet > short Term Investments
321664000
Quarters > 3 > balance Sheet > receivables
168490000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
591641000
Quarters > 3 > balance Sheet > property Plant Equipment
12607000
Quarters > 3 > balance Sheet > total Assets
744725000
Quarters > 3 > balance Sheet > payables
1615000
Quarters > 3 > balance Sheet > short Term Debt
510000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
69430000
Quarters > 3 > balance Sheet > equity
675295000
Quarters > 3 > cash Flow > net Income
131674000
Quarters > 3 > cash Flow > depreciation
536000
Quarters > 3 > cash Flow > change In Working Capital
-167721000
Quarters > 3 > cash Flow > cash From Operations
-29178000
Quarters > 3 > cash Flow > capital Expenditures
310000
Quarters > 3 > cash Flow > cash From Investing
-8725000
Quarters > 3 > cash Flow > cash From Financing
4031000
Quarters > 3 > cash Flow > net Change In Cash
-33872000
Quarters > 3 > ratios > PE
1.982838599235979
Quarters > 3 > ratios > PB
9.376479910187399
Quarters > 3 > ratios > ROE
19.498737588757507
Quarters > 3 > ratios > ROA
17.680888918728392
Quarters > 3 > ratios > FCF
-29488000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.17281027672616886
Quarters > 3 > health Score
66
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
434433000
Annuals > 0 > income Statement > cost Of Revenue
2963000
Annuals > 0 > income Statement > gross Profit
434433000
Annuals > 0 > income Statement > operating Expenses
181590000
Annuals > 0 > income Statement > operating Income
252843000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
279408000
Annuals > 0 > income Statement > net Income
275188000
Annuals > 0 > income Statement > eps
4.228587233781001
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
65078000
Annuals > 0 > income Statement > income Tax Expense
4220000
Annuals > 0 > income Statement > EBITDA
253669000
Annuals > 0 > income Statement > operating Margin
58.20068917416494
Annuals > 0 > income Statement > total Other Income Expense Net
26565000
Annuals > 0 > balance Sheet > cash
97249000
Annuals > 0 > balance Sheet > short Term Investments
321664000
Annuals > 0 > balance Sheet > receivables
168490000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
591641000
Annuals > 0 > balance Sheet > property Plant Equipment
12607000
Annuals > 0 > balance Sheet > total Assets
744725000
Annuals > 0 > balance Sheet > payables
1615000
Annuals > 0 > balance Sheet > short Term Debt
510000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
69430000
Annuals > 0 > balance Sheet > equity
675295000
Annuals > 0 > cash Flow > net Income
275188000
Annuals > 0 > cash Flow > depreciation
2895000
Annuals > 0 > cash Flow > change In Working Capital
-122610000
Annuals > 0 > cash Flow > cash From Operations
184152000
Annuals > 0 > cash Flow > capital Expenditures
1355000
Annuals > 0 > cash Flow > cash From Investing
-299483000
Annuals > 0 > cash Flow > cash From Financing
25853000
Annuals > 0 > cash Flow > net Change In Cash
-89478000
Annuals > 0 > ratios > PE
4.228587233781001
Annuals > 0 > ratios > PB
8.15769804307747
Annuals > 0 > ratios > ROE
40.75078299113721
Annuals > 0 > ratios > ROA
36.95162643928967
Annuals > 0 > ratios > FCF
182797000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.4207714423167669
Annuals > 0 > health Score
85
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
60000000
Annuals > 1 > income Statement > cost Of Revenue
3312000
Annuals > 1 > income Statement > gross Profit
60000000
Annuals > 1 > income Statement > operating Expenses
153652000
Annuals > 1 > income Statement > operating Income
-93652000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-78955000
Annuals > 1 > income Statement > net Income
-78955000
Annuals > 1 > income Statement > eps
-1.3909452013042383
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
56763559
Annuals > 1 > income Statement > income Tax Expense
-14898000
Annuals > 1 > income Statement > EBITDA
-90340000
Annuals > 1 > income Statement > operating Margin
-156.08666666666667
Annuals > 1 > income Statement > total Other Income Expense Net
14697000
Annuals > 1 > balance Sheet > cash
186727000
Annuals > 1 > balance Sheet > short Term Investments
154890000
Annuals > 1 > balance Sheet > receivables
10332000
Annuals > 1 > balance Sheet > inventories
-10332000
Annuals > 1 > balance Sheet > total Current Assets
355577000
Annuals > 1 > balance Sheet > property Plant Equipment
2149000
Annuals > 1 > balance Sheet > total Assets
357951000
Annuals > 1 > balance Sheet > payables
772000
Annuals > 1 > balance Sheet > short Term Debt
1141000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
21274000
Annuals > 1 > balance Sheet > equity
336677000
Annuals > 1 > cash Flow > net Income
-78955000
Annuals > 1 > cash Flow > depreciation
3312000
Annuals > 1 > cash Flow > change In Working Capital
-19511000
Annuals > 1 > cash Flow > cash From Operations
-70236000
Annuals > 1 > cash Flow > capital Expenditures
609000
Annuals > 1 > cash Flow > cash From Investing
-39258000
Annuals > 1 > cash Flow > cash From Financing
170477000
Annuals > 1 > cash Flow > net Change In Cash
60983000
Annuals > 1 > ratios > PE
-1.3909452013042383
Annuals > 1 > ratios > PB
14.271943938403872
Annuals > 1 > ratios > ROE
-23.451260406858797
Annuals > 1 > ratios > ROA
-22.057488315439823
Annuals > 1 > ratios > FCF
-70845000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.18075
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
26581000
Annuals > 2 > income Statement > cost Of Revenue
1032000
Annuals > 2 > income Statement > gross Profit
26581000
Annuals > 2 > income Statement > operating Expenses
157954000
Annuals > 2 > income Statement > operating Income
-131373000
Annuals > 2 > income Statement > interest Expense
3369000
Annuals > 2 > income Statement > pretax Income
-127393000
Annuals > 2 > income Statement > net Income
-123413000
Annuals > 2 > income Statement > eps
-2.516463769430396
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
49042232
Annuals > 2 > income Statement > income Tax Expense
-3980000
Annuals > 2 > income Statement > EBITDA
-128004000
Annuals > 2 > income Statement > operating Margin
-494.23648470712163
Annuals > 2 > income Statement > total Other Income Expense Net
3980000
Annuals > 2 > balance Sheet > cash
125744000
Annuals > 2 > balance Sheet > short Term Investments
111611000
Annuals > 2 > balance Sheet > receivables
52000
Annuals > 2 > balance Sheet > inventories
-94000
Annuals > 2 > balance Sheet > total Current Assets
243077000
Annuals > 2 > balance Sheet > property Plant Equipment
4626000
Annuals > 2 > balance Sheet > total Assets
247928000
Annuals > 2 > balance Sheet > payables
3640000
Annuals > 2 > balance Sheet > short Term Debt
2515000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
32320000
Annuals > 2 > balance Sheet > equity
215608000
Annuals > 2 > cash Flow > net Income
-127393000
Annuals > 2 > cash Flow > depreciation
3369000
Annuals > 2 > cash Flow > change In Working Capital
-7766000
Annuals > 2 > cash Flow > cash From Operations
-108137000
Annuals > 2 > cash Flow > capital Expenditures
795000
Annuals > 2 > cash Flow > cash From Investing
91468000
Annuals > 2 > cash Flow > cash From Financing
18838000
Annuals > 2 > cash Flow > net Change In Cash
2079000
Annuals > 2 > ratios > PE
-2.516463769430396
Annuals > 2 > ratios > PB
19.254503259619312
Annuals > 2 > ratios > ROE
-57.239527290267525
Annuals > 2 > ratios > ROA
-49.777758058791264
Annuals > 2 > ratios > FCF
-108932000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.0981151950641435
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
27357000
Annuals > 3 > income Statement > cost Of Revenue
2775000
Annuals > 3 > income Statement > gross Profit
27357000
Annuals > 3 > income Statement > operating Expenses
153202000
Annuals > 3 > income Statement > operating Income
-125845000
Annuals > 3 > income Statement > interest Expense
2481000
Annuals > 3 > income Statement > pretax Income
-125551000
Annuals > 3 > income Statement > net Income
-125551000
Annuals > 3 > income Statement > eps
-2.7103435427523874
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
46322910
Annuals > 3 > income Statement > income Tax Expense
-2924000
Annuals > 3 > income Statement > EBITDA
-123070000
Annuals > 3 > income Statement > operating Margin
-460.0102350403919
Annuals > 3 > income Statement > total Other Income Expense Net
294000
Annuals > 3 > balance Sheet > cash
123665000
Annuals > 3 > balance Sheet > short Term Investments
203235000
Annuals > 3 > balance Sheet > receivables
5333000
Annuals > 3 > balance Sheet > inventories
8503000
Annuals > 3 > balance Sheet > total Current Assets
340736000
Annuals > 3 > balance Sheet > property Plant Equipment
6734000
Annuals > 3 > balance Sheet > total Assets
347695000
Annuals > 3 > balance Sheet > payables
1600000
Annuals > 3 > balance Sheet > short Term Debt
2200000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
47674000
Annuals > 3 > balance Sheet > equity
300021000
Annuals > 3 > cash Flow > net Income
-125551000
Annuals > 3 > cash Flow > depreciation
2775000
Annuals > 3 > cash Flow > change In Working Capital
-3314000
Annuals > 3 > cash Flow > cash From Operations
-107865000
Annuals > 3 > cash Flow > capital Expenditures
1101000
Annuals > 3 > cash Flow > cash From Investing
-15860000
Annuals > 3 > cash Flow > cash From Financing
129923000
Annuals > 3 > cash Flow > net Change In Cash
6072000
Annuals > 3 > ratios > PE
-2.7103435427523874
Annuals > 3 > ratios > PB
13.069866214364994
Annuals > 3 > ratios > ROE
-41.847404015052284
Annuals > 3 > ratios > ROA
-36.10952127583083
Annuals > 3 > ratios > FCF
-108966000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.983112183353438
Annuals > 3 > health Score
26
Valuation > metrics > PE
130.2308
Valuation > metrics > PB
9.421046292976696
Valuation > final Score
1
Valuation > verdict
317.5% Overvalued
Profitability > metrics > ROE
-6.094940327251149
Profitability > metrics > ROA
-6.708286154727637
Profitability > metrics > Net Margin
-8.348684210526315
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.08715180567584442
Risk > metrics > Interest Coverage
-128.59002770083103
Risk > final Score
-454
Risk > verdict
High
Liquidity > metrics > Current Ratio
74.4759969519939
Liquidity > metrics > Quick Ratio
74.4759969519939
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
40
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
99
Prev Risks > 0
36
Prev Risks > 1
50
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:03:33.693Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.62
Earnings History > 0 > eps Estimate
-0.6133
Earnings History > 0 > eps Difference
-0.0067
Earnings History > 0 > surprise Percent
-1.0925
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.55
Earnings History > 1 > eps Estimate
-0.58
Earnings History > 1 > eps Difference
0.03
Earnings History > 1 > surprise Percent
5.1724
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.19
Earnings History > 2 > eps Estimate
0.11
Earnings History > 2 > eps Difference
-0.3
Earnings History > 2 > surprise Percent
-272.7273
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
1.98
Earnings History > 3 > eps Estimate
0.25
Earnings History > 3 > eps Difference
1.73
Earnings History > 3 > surprise Percent
692
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-04
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.54
Earnings History > 4 > eps Estimate
-0.6
Earnings History > 4 > eps Difference
0.06
Earnings History > 4 > surprise Percent
10
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.5
Earnings History > 5 > eps Estimate
-0.6
Earnings History > 5 > eps Difference
0.1
Earnings History > 5 > surprise Percent
16.6667
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
3.26
Earnings History > 6 > eps Estimate
1.19
Earnings History > 6 > eps Difference
2.07
Earnings History > 6 > surprise Percent
173.9496
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.44
Earnings History > 7 > eps Estimate
-0.03
Earnings History > 7 > eps Difference
0.47
Earnings History > 7 > surprise Percent
1566.6667
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.58
Earnings History > 8 > eps Estimate
-0.69
Earnings History > 8 > eps Difference
0.11
Earnings History > 8 > surprise Percent
15.942
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.68
Earnings History > 9 > eps Estimate
-0.65
Earnings History > 9 > eps Difference
-0.03
Earnings History > 9 > surprise Percent
-4.6154
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.67
Earnings History > 10 > eps Estimate
-0.73
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
8.2192
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-15
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.69
Earnings History > 11 > eps Estimate
-0.64
Earnings History > 11 > eps Difference
-0.05
Earnings History > 11 > surprise Percent
-7.8125
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.64
Earnings History > 12 > eps Estimate
-0.87
Earnings History > 12 > eps Difference
0.23
Earnings History > 12 > surprise Percent
26.4368
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.84
Earnings History > 13 > eps Estimate
-0.93
Earnings History > 13 > eps Difference
0.09
Earnings History > 13 > surprise Percent
9.6774
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-04
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.43
Earnings History > 14 > eps Estimate
-0.63
Earnings History > 14 > eps Difference
0.2
Earnings History > 14 > surprise Percent
31.746
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-28
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.77
Earnings History > 15 > eps Estimate
-0.78
Earnings History > 15 > eps Difference
0.01
Earnings History > 15 > surprise Percent
1.2821
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-03
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.7
Earnings History > 16 > eps Estimate
-0.67
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-4.4776
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-04
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.69
Earnings History > 17 > eps Estimate
-0.55
Earnings History > 17 > eps Difference
-0.14
Earnings History > 17 > surprise Percent
-25.4545
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-04
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.54
Earnings History > 18 > eps Estimate
-0.57
Earnings History > 18 > eps Difference
0.03
Earnings History > 18 > surprise Percent
5.2632
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-10
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.48
Earnings History > 19 > eps Estimate
-0.48
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
0
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-04
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.21
Earnings History > 20 > eps Estimate
-0.61
Earnings History > 20 > eps Difference
0.4
Earnings History > 20 > surprise Percent
65.5738
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.61
Earnings History > 21 > eps Estimate
-0.59
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-3.3898
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.72
Earnings History > 22 > eps Estimate
-0.69
Earnings History > 22 > eps Difference
-0.03
Earnings History > 22 > surprise Percent
-4.3478
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-10
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.63
Earnings History > 23 > eps Estimate
-0.65
Earnings History > 23 > eps Difference
0.02
Earnings History > 23 > surprise Percent
3.0769
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-06
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.61
Earnings History > 24 > eps Estimate
-0.71
Earnings History > 24 > eps Difference
0.1
Earnings History > 24 > surprise Percent
14.0845
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-07
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.18
Earnings History > 25 > eps Estimate
-0.28
Earnings History > 25 > eps Difference
-0.9
Earnings History > 25 > surprise Percent
-321.4286
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-08
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.58
Earnings History > 26 > eps Estimate
-0.59
Earnings History > 26 > eps Difference
0.01
Earnings History > 26 > surprise Percent
1.6949
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-12
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.57
Earnings History > 27 > eps Estimate
-0.47
Earnings History > 27 > eps Difference
-0.1
Earnings History > 27 > surprise Percent
-21.2766
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-06
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.38
Earnings History > 28 > eps Estimate
-0.37
Earnings History > 28 > eps Difference
-0.01
Earnings History > 28 > surprise Percent
-2.7027
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-07
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.41
Earnings History > 29 > eps Estimate
-0.35
Earnings History > 29 > eps Difference
-0.06
Earnings History > 29 > surprise Percent
-17.1429
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-09
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.36
Earnings History > 30 > eps Estimate
-0.29
Earnings History > 30 > eps Difference
-0.07
Earnings History > 30 > surprise Percent
-24.1379
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-07
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.15
Earnings History > 31 > eps Estimate
-0.35
Earnings History > 31 > eps Difference
0.2
Earnings History > 31 > surprise Percent
57.1429
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-06
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.29
Earnings History > 32 > eps Estimate
-0.71
Earnings History > 32 > eps Difference
0.42
Earnings History > 32 > surprise Percent
59.1549
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-08
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.89
Earnings History > 33 > eps Estimate
-0.86
Earnings History > 33 > eps Difference
-0.03
Earnings History > 33 > surprise Percent
-3.4884
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-10
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.84
Earnings History > 34 > eps Estimate
-0.61
Earnings History > 34 > eps Difference
-0.23
Earnings History > 34 > surprise Percent
-37.7049
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-07
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.67
Earnings History > 35 > eps Estimate
-0.52
Earnings History > 35 > eps Difference
-0.15
Earnings History > 35 > surprise Percent
-28.8462
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-11-14
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.87
Earnings History > 36 > eps Estimate
-0.58
Earnings History > 36 > eps Difference
-0.29
Earnings History > 36 > surprise Percent
-50
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-09-15
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-19.07
Earnings History > 37 > eps Estimate
-0.77
Earnings History > 37 > eps Difference
-18.3
Earnings History > 37 > surprise Percent
-2376.6234
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AProtagonist Therapeutics (NASDAQ:PTGX) Hits New 1-Year High - What's Next? MarketBeat
Read more →Protagonist Therapeutics, Inc. $PTGX Shares Purchased by BVF Inc. IL MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$90.6923
Analyst Picks
Strong Buy
5
Buy
4
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 107.74% of the total shares of Protagonist Therapeutics Inc
1.
BlackRock Inc(15.48%)
since
2025/06/30
2.
Farallon Capital Management, L.L.C.(9.921%)
since
2025/06/30
3.
RTW INVESTMENTS, LLC(9.2528%)
since
2025/06/30
4.
Vanguard Group Inc(7.0061%)
since
2025/06/30
5.
iShares Core S&P Small-Cap ETF(5.9291%)
since
2025/08/31
6.
Deep Track Capital, LP(5.2175%)
since
2025/06/30
7.
Bvf Inc(5.1615%)
since
2025/06/30
8.
State Street Corp(5.1559%)
since
2025/06/30
9.
UBS Group AG(4.0206%)
since
2025/06/30
10.
Johnson & Johnson(3.9369%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(3.1182%)
since
2025/07/31
12.
Geode Capital Management, LLC(2.3215%)
since
2025/06/30
13.
iShares Russell 2000 ETF(2.2521%)
since
2025/08/31
14.
Adage Capital Partners Gp LLC(1.7557%)
since
2025/06/30
15.
COMMODORE CAPITAL LP(1.728%)
since
2025/06/30
16.
Perceptive Advisors LLC(1.7271%)
since
2025/06/30
17.
Wellington Management Company LLP(1.6681%)
since
2025/06/30
18.
SPDR® S&P Biotech ETF(1.5802%)
since
2025/08/31
19.
ADAR1 Capital Management LLC(1.5239%)
since
2025/06/30
20.
Woodline Partners LP(1.522%)
since
2025/06/30
21.
T. Rowe Price Associates, Inc.(1.5057%)
since
2025/06/30
22.
T. Rowe Price Health Sciences(1.4191%)
since
2025/07/31
23.
Morgan Stanley - Brokerage Accounts(1.3968%)
since
2025/06/30
24.
Bank of America Corp(1.3693%)
since
2025/06/30
25.
Jefferies Financial Group Inc(1.3245%)
since
2025/06/30
26.
Vanguard Institutional Extnd Mkt Idx Tr(1.0699%)
since
2025/07/31
27.
Fidelity Small Cap Index(0.9391%)
since
2025/06/30
28.
SPDR® Portfolio S&P 600™ Sm Cap ETF(0.881%)
since
2025/08/29
29.
iShares S&P Small-Cap 600 Growth ETF(0.8573%)
since
2025/08/31
30.
iShares Russell 2000 Growth ETF(0.8233%)
since
2025/08/31
31.
Fidelity Select Biotechnology(0.7668%)
since
2025/07/31
32.
Vanguard Tax-Managed Small Cap Adm(0.655%)
since
2025/07/31
33.
BlackRock Health Sciences Opps Inv A(0.653%)
since
2025/07/31
34.
American Century Small Cap Growth Inv(0.5969%)
since
2025/06/30
35.
American Century U.S. Small Cap Growth(0.5969%)
since
2025/06/30
36.
iShares Biotechnology ETF(0.559%)
since
2025/08/31
37.
Pictet-Biotech P USD(0.5515%)
since
2025/05/31
38.
Fidelity Extended Market Index(0.5394%)
since
2025/07/31
39.
SPDR® S&P 600 Small Cap Growth ETF(0.4848%)
since
2025/08/31
40.
Schwab US Small-Cap ETFâ„¢(0.4729%)
since
2025/08/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.62
EPS Estimate
-0.6133
EPS Difference
-0.0067
Surprise Percent
-1.0925%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.